Resultados de búsqueda - Konstanze Döhner

Limitar resultados
  1. 1
    Molecular characterization of acute myeloid leukemia

    Molecular characterization of acute myeloid leukemia por Konstanze Döhner, H. Döhner

    Publicado 2008
    Enlace del recurso Enlace del recurso
    Editorial
    Agregar a favoritos
    Guardado en:
  2. 2
    Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation?

    Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation? por Peter Paschka, Konstanze Döhner

    Publicado 2013
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  3. 3
    TET Genes: new players in DNA demethylation and important determinants for stemness

    TET Genes: new players in DNA demethylation and important determinants for stemness por Fabian Mohr, Konstanze Döhner, Christian Buske, Vijay P.S. Rawat

    Publicado 2010
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  4. 4
    Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B

    Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B por Stefan Fröhling, Richard F. Schlenk, Sabine Käyser, Martina Morhardt, Axel Benner, Konstanze Döhner, Hartmut Döhner

    Publicado 2006
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1mut)

    Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1mut) por Jochen Greiner, Vanessa Schneider, Michael Schmitt, Marlies Götz, Konstanze Döhner, Markus Wiesneth, Hartmut Döhner, Susanne Hofmann

    Publicado 2013
    Enlace del recurso Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:
  6. 6
    Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms

    Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms por Kerstin Maria Kampa-Schittenhelm, Michael C. Heinrich, Figen Akmut, Hartmut Döhner, Konstanze Döhner, Marcus M. Schittenhelm

    Publicado 2013
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm

    Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm por Stefan Fröhling, Richard F. Schlenk, Jochen Breitruck, Axel Benner, Sylvia Kreitmeier, Karen Tobis, Hartmut Döhner, Konstanze Döhner

    Publicado 2002
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia

    Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia por Lars Bullinger, Konstanze Döhner, Eric Bair, Stefan Fröhling, Richard F. Schlenk, Robert Tibshirani, Hartmut Döhner, Jonathan R. Pollack

    Publicado 2004
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Quantitative DNA methylation predicts survival in adult acute myeloid leukemia

    Quantitative DNA methylation predicts survival in adult acute myeloid leukemia por Lars Bullinger, Mathias Ehrich, Konstanze Döhner, Richard F. Schlenk, Hartmut Döhner, Matthew R. Nelson, Dirk van den Boom

    Publicado 2009
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia

    Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia por Brenton G. Mar, Lars Bullinger, Ellen M. Basu, Krysta Schlis, Lewis B. Silverman, Konstanze Döhner, Scott A. Armstrong

    Publicado 2012
    Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:
  11. 11
    SEURAT: Visual analytics for the integrated analysis of microarray data

    SEURAT: Visual analytics for the integrated analysis of microarray data por Alexander Gribov, Martin Sill, Sonja C Lück, Frank G. Rücker, Konstanze Döhner, Lars Bullinger, Axel Benner, Antony Unwin

    Publicado 2010
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia

    Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia por Hartmut Döhner, Stephan Stilgenbauer, Axel Benner, Elke Leupolt, Alexander Kröber, Lars Bullinger, Konstanze Döhner, Martin Bentz, Peter Lichter

    Publicado 2000
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    <i>CEBPA</i> Mutations in Younger Adults With Acute Myeloid Leukemia and Normal Cytogenetics: Prognostic Relevance and Analysis of Cooperating Mutations

    <i>CEBPA</i> Mutations in Younger Adults With Acute Myeloid Leukemia and Normal Cytogenetics: Prognostic Relevance and Analysis of Cooperating Mutations por Stefan Fröhling, Richard F. Schlenk, Ina Stolze, Jörg Bihlmayr, Axel Benner, Sylvia Kreitmeier, Karen Tobis, Hartmut Döhner, Konstanze Döhner

    Publicado 2004
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    Functional Classification of TP53 Mutations in Acute Myeloid Leukemia

    Functional Classification of TP53 Mutations in Acute Myeloid Leukemia por Sayantanee Dutta, Gudrun Pregartner, Frank G. Rücker, Ellen Heitzer, Armin Zebisch, Lars Bullinger, Andrea Berghold, Konstanze Döhner, Heinz Sill

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  15. 15
    DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients &gt;60 years with acute myeloid leukemia who are ineligible for induction chemotherapy

    DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (V... por Olga Grishina, Claudia Schmoor, Konstanze Döhner, Björn Hackanson, Beate Lubrich, Annette M. May, Caroline Cieslik, Michael J. Müller, Michael Lübbert

    Publicado 2015
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  16. 16
    Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

    Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations por Konstanze Döhner, Richard F. Schlenk, Marianne Habdank, Claudia Scholl, Frank G. Rücker, Andrea Corbacioglu, Lars Bullinger, Stefan Fröhling, Hartmut Döhner

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  17. 17
    Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of <i>Mycobacterium tuberculosis</i> in Human Macrophages

    Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of <i>Mycobacterium tuberculosis</i> in Human Macrophages por Heiko Bruns, Frank Stegelmann, Mario Fabri, Konstanze Döhner, Ger van Zandbergen, Manfred Wagner, Mhairi Skinner, Robert L. Modlin, Steffen Stenger

    Publicado 2012
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    ABCB1 Expression in Acute Myeloid Leukemia (AML): A Possible Predictive Value for Treatment Resistance?

    ABCB1 Expression in Acute Myeloid Leukemia (AML): A Possible Predictive Value for Treatment Resistance? por Stephany Corrêa, Eliana Abdelhay, Peter Paschka, Verena I. Gaidzik, Rocı́o Hassan, Rainer Claus, Richard F. Schlenk, Konstanze Döhner, Lars Bullinger

    Publicado 2014
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  19. 19
    getITD for FLT3-ITD-based MRD monitoring in AML

    getITD for FLT3-ITD-based MRD monitoring in AML por Tamara J. Blätte, Laura K. Schmalbrock, Sabrina Skambraks, Susanne Lux, Sibylle Cocciardi, Anna Dolnik, Hartmut Döhner, Konstanze Döhner, Lars Bullinger

    Publicado 2019
    Enlace del recurso Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:
  20. 20
    Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by<i>DNMT3A</i>mutational status and associated with predominant hypomethylation of HOX genes

    Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by<i>DNMT3A</i>mutational status and associated with predominant hypomethylation of HOX ge... por Ying Qu, Andreas Lennartsson, Verena I. Gaidzik, Stefan Deneberg, Mohsen Karimi, Sofia Bengtzén, Martin Höglund, Lars Bullinger, Konstanze Döhner, Sören Lehmann

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: